← 產業報告目錄
Oxycodone Hydrochloride Market Size, Share & Trends Analysis Report By Type (Controlled-Release, Immediate-Release), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, And By Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-08頁數 170報告編號 INSIGHTACE-9cbcd1b667
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Oxycodone Hydrochloride Market on a global scale was estimated at USD 412.4 Mn in 2023 and is anticipated to attain USD 572.8 Mn by 2031, with a projected CAGR of 4.33% between 2024 and 2031.
At its core, Oxycodone Hydrochloride pertains to a prescribed opioid analgesic utilized for the management of moderate to severe pain, particularly when alternative analgesics, such as non-opioid medicines, prove inadequat. Stakeholders across the healthcare landscape are escalatingly turning to these solutions to meet contemporary demands.
The market's upward path is propelled by escalating healthcare spending, technological evolution, and the escalating focus on personalized and precision-based approaches in healthcare.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, propelled by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Oxycodone Hydrochloride Market Snapshot
Chapter 4. Global Oxycodone Hydrochloride Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global Oxycodone Hydrochloride Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Oxycodone Hydrochloride Industry Trends
Chapter 5. Oxycodone Hydrochloride Market Segmentation 1: By Type, Estimates & Trend Analysis
5.1. Market Share by Type, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type:
5.2.1. Controlled-Release
5.2.2. Immediate-Release
Chapter 6. Oxycodone Hydrochloride Market Segmentation 2: By Route of Administration, Estimates & Trend Analysis
6.1. Market Share by Route of Administration, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Route of Administration:
6.2.1. Oral
6.2.2. Parenteral
Chapter 7. Oxycodone Hydrochloride Market Segmentation 3: By Distribution Channel, Estimates & Trend Analysis
7.1. Market Share by Distribution Channel, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Distribution Channels:
7.2.1. Hospital Pharmacies
7.2.2. Retail Pharmacies
7.2.3. Online Pharmacies
Chapter 8. Oxycodone Hydrochloride Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. Global Oxycodone Hydrochloride Market, Regional Snapshot 2023 & 2031
8.2. North America
8.2.1. North America Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Country, 2019-2031
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.2.3. North America Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2019-2031
8.2.4. North America Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2019-2031
8.3. Europe
8.3.1. Europe Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Country, 2019-2031
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.3.3. Europe Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2019-2031
8.3.4. Europe Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2019-2031
8.4. Asia Pacific
8.4.1. Asia Pacific Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Country, 2019-2031
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.4.3. Asia Pacific Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts By Route of Administration, 2019-2031
8.4.4. Asia Pacific Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2019-2031
8.5. Latin America
8.5.1. Latin America Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Country, 2019-2031
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.5.3. Latin America Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2019-2031
8.5.4. Latin America Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2019-2031
8.6. Middle East & Africa
8.6.1. Middle East & Africa Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.6.3. Middle East & Africa Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2019-2031
8.6.4. Middle East & Africa Oxycodone Hydrochloride Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Eli Lilly and Company
9.2.1.1. Business Overview
9.2.1.2. Key Product/Service Offerings
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Gilead Sciences, Inc.
9.2.3. Manus Aktteva Biopharma LLP
9.2.4. Arevipharma GmbH
9.2.5. Saneca Pharma a.s.
9.2.6. Cipla Ltd.
9.2.7. Noramco, Inc.
9.2.8. MacFarlan Smith
9.2.9. Teva Pharmaceutical Industries Ltd.
9.2.10. Taj Pharma
9.2.11. Chattem Chemicals Inc
9.2.12. Mayne Pharma Group Ltd.
9.2.13. Dr. Reddy's Laboratories Limited
9.2.14. Siegfried
9.2.15. Rhodes Pharmaceuticals L.P.
9.2.16. Mallinckrodt Pharmaceuticals
9.2.17. Johnson & Johnson
9.2.18. Bristol-Myers Squibb Company
9.2.19. Sun Pharmaceutical Industries Limited
9.2.20. Lupin Limited
9.2.21. Sanofi S.A.
9.2.22. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們